Evidence map›Paper›PMID 41501113›Full record

ArticleScientific reports2026

Enhancing Alzheimer's disease classification with a transformer-based model using self-supervised learning.

M Priyadharshini, V Murugesh, Oleg Rybin

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M PriyadharshiniDepartment of Computer Science & Engineering, Faculty of Science and Technology (IcfaiTech), Foundation for Higher Education, ICFAI, Hyderabad, 501 203, India.
V MurugeshSchool of Computer Science, Coventry University Kazakhstan, Astana, Kazakhstan. murugesh72@gmail.com.
Oleg RybinSchool of Radio Physics, Biomedical Electronics & Computer Systems, Karazin Kharkiv National University, Kharkiv, 61022, V.N, Ukraine. oleg.rybin@karazin.ua.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease and the current diagnosis tools, which are used, including clinical examination and neuroimaging, are costly, time consuming and complicated to generalize across demographics. Traditional machine learning (ML) methods such as Support Vector Machines (SVM), LightGBM, and Random Forest (RF) are known to be having weakness in terms of feature selection, class imbalance, and generalization. This paper presents a new Enhanced TabTransformer with Self-Supervised Learning (ETT-SSL) framework of AD classification. The structure combines the transformer-based architecture, self-supervised learning (SSL) for feature representation, SHAP-based feature selection, and the use of SMOTE to balance classes. Experimental results also indicate that ETT-SSL reaches a high accuracy of 95.8%, which is a much better result than baseline models (SVM: 72.1, RF: 78.3, LightGBM: 80.5) and even the standard TabTransformer (85.2%). Additionally, ETT-SSL offers greater accuracy and improved recall, overcoming the issue of false negatives in AD diagnosis. SHAP analysis can be used to improve transparency in clinical decision-making by making use of the model interpretability. The proposed framework recommends a salivary, interpretability and clinically practical methodology that can be used to expand to multimodal data source (e.g. MRI scans, genomic markers and electronic health records) to improve accuracy and generalisability.

Indexed as

Alzheimer DiseaseSupervised Machine LearningBoosting Machine Learning AlgorithmsClassification AlgorithmsHumansRandom ForestSupport Vector MachineAlzheimer disease detectionEarly diagnosis of Alzheimer’sNeurodegenerative disease detectionSelf-supervised learning (SSL)Structured medical data analysis

Identifiers

PMID41501113
PMCPMC12852784

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.